ArticleFrontiers in oncology2025

Impact on outcomes of ultra hypofractionation or hypofractionation regimens and proton or Xrays therapy in a phase III randomized controlled trial MC1635.

Carlos Vargas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.